Flushes and Sertraline Trial
Menopause-Hot Flashes
About this trial
This is an interventional treatment trial for Menopause-Hot Flashes focused on measuring Menopausal Symptoms, Hot flashes
Eligibility Criteria
Inclusion Criteria: Age 40 - 60 years old Report > 14 hot flushes per week Willing to be randomized to sertraline or placebo Sign informed consent Exclusion Criteria: History of bilateral oophorectomy Breast or ovarian cancer Liver disease Kidney disease requiring dialysis History of major depression (reported history of depression requiring therapy, hospitalization for depression, taking antidepressant drugs, history of suicide attempt) History of bipolar affective disorder (reported history of bipolar disorder requiring therapy, medications, hospitalized for bipolar disorder) Seizure disorder History of hypersensitivity to sertraline or to SSRIs Pregnancy or breast feeding Any medical or psychiatric condition which, in the investigator's opinion, would preclude the participant from adhering to the protocol or completing the trial; No estrogens or progestins for 3 months prior to screening or during enrollment Selective estrogen receptor modulators (SERMS) The following medications: clonidine, gabapentin, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, selective serotonin reuptake inhibitors (SSRIs), megesterol , oral contraceptives, androgens; and medications that are listed on the Pfizer Pharmaceutical drug insert as "contraindicated"
Sites / Locations
- UCSF Women's Health Clinical Research Center